GOOD MEDICINE CHOICE, INC., a collaborative network of research scientists and practitioners, has launched a new health blog, Podcast and product line in their efforts to fight the coronavirus co·ro·na·vi·rus : any of a family (Coronaviridae) of single-stranded RNA viruses that have a lipid envelope studded with club-shaped projections, infect birds and many mammals including humans, and include the causative agents of MERS, SARS, and COVID-19 pandemic (pan·dem·ic) : an outbreak of a disease that occurs over a wide geographic area and affects an exceptionally high proportion of the population : a pandemic outbreak of a disease.. The website, GoodMedicineChoiceNetwork.com, offers guidance on maintaining a healthy immune system : the bodily system that protects the body from foreign substances, cells, and tissues by producing the immune response and that includes especially the thymus, spleen, lymph nodes, special deposits of lymphoid tissue (as in the gastrointestinal tract and bone marrow), macrophages, lymphocytes including the B cells and T cells, and antibodies. and supplemental products to protect against chronic and infectious diseases, with current focus on COVID-19 \ ˈkō-vid-nīn-ˈtēn : a mild to severe respiratory illness that is caused by a coronavirus (Severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus), is transmitted chiefly by contact with infectious material (such as respiratory droplets), and is characterized especially by fever, cough, and shortness of breath and may progress to pneumonia and respiratory failure. .
The site will donate 10% of profits from product sales to support charities, including Advocates for Disabled Americans, Veterans, Police, Fireman & Families (ADA VETs).
GOOD MEDICINE CHOICE, INC., (GMC) has researched and developed a variety of health products including anti-inflammatory and antioxidant supplements, multivitamins and essential oils. Visit GoodMedicineChoiceNetwork/Shop/ to learn more. The site also hosts a new podcast, Coronavirus Education, which is available for download on Apple iTunes, Stitcher and TuneIn.
The Good Medicine ChoiceTM Network website provides insights from specialists with expertise in telemedicine, chronic disease, immune system health, integrative medicine, and pharmaceutical and medical device research and development. Main partners of GMC include MJA Healthcare Network, which leads the company in intellectual property and product development, and GoMD Virtual Healthcare Corp., championing the company’s telemedicine efforts.
Group Leads Coronavirus Research, Podcast and Virtual Healthcare Network
GMC has spent the last three months at the forefront of efforts to fight the coronavirus pandemic. Formed in 2016, GMC established a virtual healthcare network to provide medical assessments during the shutdown and has participated in providing personal protective equipment (PPE) for healthcare organizations. The group is currently leading a six-month research study into Cytokine Storms resulting from COVID-19 disease. The principals include Mikhail Artamonov, MD; Thomas J. Lewis, PhD; and Michael Carter, MD.
Good Medicine Choice Network focuses on how to avoid exposure to SARS-CoV-2 ˈsärz-kō-ˈvē-ˈtü : the coronavirus (Severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus) that is the causative agent of COVID-19 and other infectious disease, risks associated with severe symptoms from COVID-19, and how individuals can measure and reverse their risks of chronic conditions and infection in·fec·tion | \ in-ˈfek-shən a : the state produced by the establishment of one or more pathogenic agents (such as a bacteria, protozoans, or viruses) in or on the body of a suitable host b : a disease resulting from infection. The website provides information on COVID-19 testing and treatment developments and resources related to coping during the pandemic.
“I’m particularly proud of the fact that 10% of the company’s profits are contributed to charities including ADA VETs, an organization working closely with families of disabled veterans,” says Dr. Artamonov, CEO.
Podcast Features Latest Research on SARS-CoV-2 and COVID-19
The Coronavirus Education Podcast covers topics that explore what it means to be immunocompromised im·mu·no·com·pro·mised | \ ˌi-myə-nō-ˈkäm-prə-ˌmīzd : having the immune system impaired or weakened (as by drugs or illness)., how to strengthen immunity from viruses, and research into potential treatments for COVID-19.
“We aim to provide information on how to protect yourself and your family not just during the current pandemic crisis but also in the future, as our highly connected world presents the risk of future threats to your health,” added Lewis.
About the Good Medicine Choice Network Experts
Dr. Mikhail Artamonov, CEO, is a medical practitioner and cofounder of GoMD, a virtual healthcare provider that has worked to develop technologies for the healthcare industry. Dr. Artamonov earned his medical degree the 1st Moscow Medical Sechenov School, and over the course of his career trained in several specialties including Neurology and Physiatry, Anesthesiology, Psychiatry, and Internal and Integrative Medicine. Dr. Artamonov trained in major institutions around the world including Harvard and Cornell universities. He is Board Certified in eight major areas of Medicine, including Physical Medicine and Rehabilitation; Pain Medicine; Functional, Regenerative and Anti-Aging Medicine.
Thomas J. Lewis, Ph.D. studied at MIT and continued his education at Harvard School of Public Health. Since his father’s death 20 years ago of Alzheimer’s disease, he has dedicated his life to determining how to better predict Alzheimer’s and chronic diseases with a mission to replace the current “sick care” standard-of-care approach with a true “health care” approach. He is a healthcare professional with expertise in toxic substances, drug development, biotechnology and medical protocol development. Working with key clinicians at Harvard Medical School, his team developed an advanced diagnostic protocol, “4-Dimensions of Health,” utilizing AI-driven algorithms to measure risks and other determinants of chronic disease root cause prevention, screening and treatment.
Dr. Michael Carter is a board-certified physician and CMO of Functional Medicine at GoMD and Health Revival Partners. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine. He has obtained certifications in topics including stem cells, energy medicine, nutrition and advanced peptides. Dr. Carter is co-inventor of the 4-Dimensions of Health program. He also is a member of the American Academy of Anti-Aging Medicine and the Institute for Functional. He completed his medical degree at Howard University and College of Medicine and his residency at Emory University School of Medicine.